Acute spinal cord injury, part I: Pathophysiologic mechanisms

Clinical Neuropharmacology

Volumn 24, Issue 5, 2001, Pages 254-264

  Dumont, Randall J ^a   Okonkwo, David O ^b   Verma, Subodh ^c   Hurlbert, R John ^c   Boulos, Paul T ^b   Ellegala, Dilantha B ^b   Dumont, Aaron S ^b,c,d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Pathophysiologic mechanisms; Secondary injury; Spinal cord injury

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; CALCIUM ION; CALPAIN; CASPASE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOCHROME C; CYTOKINE; GLUTAMATE RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR;

APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; ELECTROLYTE DISTURBANCE; HUMAN; MITOCHONDRION; NERVE CELL NECROSIS; NERVOUS SYSTEM INJURY; NEUROTRANSMISSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPERFUSION INJURY; SPINAL CORD HEMORRHAGE; SPINAL CORD INJURY; SPINAL CORD ISCHEMIA;

ACUTE DISEASE; ANIMALS; APOPTOSIS; CELL DEATH; HEMORRHAGE; HUMANS; ISCHEMIA; SPINAL CORD INJURIES;

EID: 0034806962     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-200109000-00002     Document Type: Article

References (131)

1. Incidence of acute traumatic spinal cord injury in the United States, 1970-1977
2. Care of the multiply injured patient with cervical spine injury
3. Clinical and research considerations in spinal cord injury
4. Spinal injury pain
5. Description of nonfatal spinal cord injury using a hospital-based registry
6. Statistical information pertaining to some of the most commonly asked questions about spinal cord injury
7. Novel pharmacologic strategies in the treatment of experimental traumatic brain injury: 1998
8. New pharmacologic approaches to acute spinal cord injury
9. Pathophysiology and pathology of spinal cord injury
10. Management of acute spinal cord injury
11. Functional recovery after decompressive operation for thoracic and lumbar spine fractures
12. Functional recovery after decompressive operation for cervical spine fractures
13. Results of reduction and stabilization of the severely fractured thoracic and lumbar spine
14. The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia - Part I
15. Lateral extracavitary approach to traumatic lesions of the thoracic and lumbar spine
16. Prediction of mobility gains in patients with cervical spine injuries
17. Management of acute unstable thoracolumbar (T-11-L1) fractures with and without neurological deficit
18. Prognosis in spinal cord injury with special reference to patients with motor paralysis and sensory preservation
19. Spinal cord syndromes with physiological and anatomic correlations
20. Spinal cord injury without radiographic abnormalities in children
21. The disturbances of circulation in traumatic paraplegia in acute and late stages: A pathological study
22. Secondary injury mechanisms in acute spinal cord injury
23. Pathophysiology of spinal cord trauma
24. Recovery of motor function after spinal cord injury - A randomized, placebo-controlled trial with GM-1 ganglioside
25. Neuroprotection by the selective cyclooxygenase-2 inhibitor SC-236 results in improvements in behavioral deficits induced by reversible spinal cord ischemia
26. Central axons in injured cat spinal cord recover electophysiological function following remyelination by Schwann cells
27. Neurogenic shock
28. Acute cardiovascular effects of experimental spinal cord injury
29. Silicone rubber microangiography of acute spinal cord injury
30. Three-dimensional analysis of the vascular system in the rat spinal cord with scanning electron microscopy of vascular corrosion casts - Part 1: Normal spinal cord
31. Three-dimensional analysis of the vascular system in the rat spinal cord with scanning electron microscopy of vascular corrosion casts - Part 2: Acute spinal cord injury
32. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms
33. Review of experimental spinal cord injury with emphasis on the local systemic circulatory effects
34. Spinal cord injury: Review of basic and applied research
35. Morphological evidence of microcirculatory disturbances in experimental spinal cord trauma
36. Review of the effect of spinal cord trauma on the vessels and blood flow in the spinal cord
37. Antioxidant therapy: A new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury
38. Excitatory amino acids as a final common pathway for neurologic disorders
39. In vivo detection of superoxide anion production by the brain using a cytochrome c electrode
40. Augmentation of nitric oxide, superoxide and peroxynitrite production during cerebral ischemia and reperfusion in the rat
41. Peroxynitrite formation in focal cerebral ischemia-reperfusion in rats occurs predominantly in the peri-infarct region
42. Generation of nitric oxide and superoxide during reperfusion after focal ischemia in rats
43. Free radical pathways in CNS injury
44. Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle carotid artery occlusion
45. Depletion of brain glutathione by buthionine sulfoximine enhances cerebral ischemic injury in rats
46. Regional measurement of NO formed in vivo during brain ischemia
47. Oxypurinol attenuates hydroxyl radical production during ischemia/reperfusion injury of the rat cerebral cortex: An ESR study
48. Mitochondrial generation of reactive oxygen species after brain ischemia in the rat
49. Relationship between free radical production and lipid peroxidation during ischemia-reperfusion injury in the rat brain
50. Electron paramagnetic resonance (EPR) detection of nitric oxide produced during forebrain ischemia of the rat
51. Nitric oxide changes in rat brain after transient middle cerebral artery occlusion
52. Detection of free radicals during brain ischemia and reperfusion by spin trapping and microdialysis
53. Global cerebral ischemia in the rat: Online monitoring of oxygen free radical production using chemiluminescence in vivo
54. Oxidative damage to brain proteins, loss of glutamine synthetase activity and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain
55. Influence of transient ischemia in lipid-soluble antioxidants, free fatty acids and energy metabolites in rat brain
56. Pretreatment with α-phenyl-n-tert-butyl-nitrone (PBN) improves energy metabolism after spinal cord injury in rats
57. N-methyl-D-aspartate antagonist MK801 improves outcome after traumatic spinal cord injury in rats: Behavioral, anatomic, and neurochemical studies
58. A potential role for excitotoxins in the pathophysiology of spinal cord injury
59. Alteration in extracellular amino acids after traumatic spinal cord injury
60. Molecular neurobiology of glutamate receptors
61. No protective effect of the NMDA antagonist memantine in experimental spinal cord injuries
62. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma
63. Neurotoxicity of excitatory amino acids
64. Ion dependence of glutamate neurotoxicity
65. The opioid receptor antagonist naloxone influences the pathophysiology of spinal cord injury
66. The effect of the sodium channel blocker QX-314 on recovery after acute spinal cord injury
67. Calcium and ischemic injury
68. Calcium dependence of toxic cell death: A final common pathway
69. Peroxynitrite versus hydroxyl radical: The role of nitric oxide in superoxide-dependent cerebral injury
70. NO, nitrosonium ions, nitroxide ions, nitrosothiols and iron nitrosyls in biology: A chemist's perspective
71. Glutathione peroxidase: The primary agent for the elimination of hydrogen peroxide in erythrocytes
72. Gases as biological messengers: Nitric oxide and carbon monoxide in the brain
73. Free radicals and neuronal cell death
74. Mechanisms of nitric oxide mediated neurotoxicity in primary brain cultures
75. Superoxide dismutases
76. The L-arginine-nitric oxide pathway
77. DNA fragmentation in focal cortical freeze injury of rats
78. Acute management of the head injury patient
79. Mitochondrial participation in ischemic and traumatic neural cell death
80. Calpain activity and expression increased in activated glial and inflammatory cells in penumbra of spinal cord injury lesion
81. A pharmacological analysis of the pathophysiological mechanisms of posttraumatic spinal cord ischemia
82. Alteration of thromboxane and prostacyclin levels in experimental spinal cord injury
83. Altered levels of PGF in cat spinal cord tissue after traumatic injury
84. Alterations in lipid metabolism, Na, K-ATPase activity and tissue water content of spinal cord after experimental traumatic injury
85. Persistent accumulation of cyclooxygenase-1 (COX-1) expressing microglia/macrophages and upregulation by endothelium following spinal cord injury
86. Role of cyclooxygenase 2 in acute spinal cord injury
87. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex
88. Immediate consequences of spinal cord injury: Possible role of potassium in axonal conduction block
89. Antagonists of excitatory amino acids and endogenous opioid peptides in the treatment of experimental central nervous system injury
90. Neuropeptides and central nervous system injury
91. Neurotrophic factors in central nervous system trauma
92. Degeneration and regeneration of axons in the lesioned spinal cord
93. Concept of autoimmunity following spinal cord injury: Possible roles for T lymphocytes in the traumatized central nervous system
94. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide
95. Involvement of an intercellular adhesion molecule 1-dependent pathway in the pathogenesis of secondary changes after spinal cord injury in rats
96. Spinal cord injury in ICAM-1-deficient mice: Assessment of functional and histopathological outcome
97. Improved recovery after spinal cord trauma in ICAM-1 and P-selectin knockout mice
98. Effects of pro-inflammatory cytokines in experimental spinal cord injury
99. The macrophage in acute neural injury: Changes in cell numbers over time and levels of cytokine production in mammalian central and peripheral nervous systems
100. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats
101. Neuroprotective effects of interleukin-10 following excitotoxic spinal cord injury
102. Chemokine antagonist infusion attenuates cellular infiltration following spinal cord contusion injury in rat
103. Traumatic spinal cord injury induces nuclear factor-kappaB activation
104. Apoptosis after traumatic human spinal cord injury
105. Caspase-3 inhibition is neuroprotective after spinal cord injury
106. Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat
107. Differential activation of caspases after traumatic spinal cord injury in the rat
108. Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury
109. Apoptosis of microglia and oligodendrocytes after spinal cord contusion in rats
110. Apoptotic cells associated with Wallerian degeneration after experimental spinal cord injury: A possible mechanism of oligodendroglial death
111. Apoptosis of oligodendrocytes occurs for long distances away from the primary injury after compression trauma to rat spinal cord
112. Functional role and therapeutic implications of neuronal caspase-1 and -3 in a mouse model of traumatic spinal cord injury
113. Delayed selective motor neuron death and fas antigen induction after spinal cord ischemia in rabbits
114. Nitric oxide via macrophage iNOS induces apoptosis following traumatic spinal cord injury
115. Rapid upregulation of caspase-3 in rat spinal cord after injury: mRNA, protein, and cellular localization correlates with apoptotic cell death
116. Caspase pathways, neuronal apoptosis, and CNS injury
117. Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons
118. Caspase-9
119. Mitochondrial dysfunction after experimental and human brain injury and its possible reversal with a selective N-type calcium channel antagonist (SNX-111)
120. Mitochondrial dysfunction and calcium perturbation induced by traumatic brain injury
121. Amelioration of mitochondrial function by a novel antioxidant U-101033E following traumatic brain injury in rats
122. Mitochondrial dysfunction after experimental traumatic brain injury: Combined efficacy of SNX-111 and U-101033E
123. Effect of N-acetylcysteine on mitochondrial function following traumatic brain injury in rats
124. Cyclosporin A attenuates acute mitochondrial dysfunction following traumatic brain injury
125. An intrathecal bolus of cyclosporin A before injury preserves mitochondrial integrity and attenuates axonal disruption in traumatic brain injury
126. Mitochondria, calcium regulation, and acute glutamate excitotoxicity in cultured cerebellar granule cells
127. Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate
128. Mitochondrial dysfunction is a primary event in glutamate neurotoxicity
129. Glutamate-induced neuron death requires mitochondrial calcium uptake
130. 2+ exchange buffer glutamate-induced calcium loads in cultured cortical neurons
131. Endogenous opioids may mediate secondary damage after experimental brain injury